Update: STAAR Surgical Shares Rise After Wedbush Upgrade Following Q1 Results

MT Newswires Live05-15

(Updates with recent stock movement and upgrade from Wedbush in headline and first two paragraphs.)

STAAR Surgical (STAA) shares rose more than 10% in Thursday afternoon trading after Wedbush Securities upgraded the company's stock following the company's Q1 results that beat market expectations.

The investment firm upgraded the stock to outperform from neutral and adjusted the price target to $40 from $26. Trading volume of STAAR stood at more than 2.7 million shares against a daily average of about 1.3 million.

The company reported Q1 earnings late Wednesday of $0.10 per diluted share, swinging from a loss of $1.10 a year earlier.

Analysts surveyed by FactSet expected a loss of $0.05.

Net sales for the three months ended April 3 rose to $93.5 million from $42.6 million a year earlier.

Analysts polled by FactSet expected $78.7 million.

Price: 32.53, Change: +3.13, Percent Change: +10.63

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2635174741?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-15 02:30","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2635174741","market":"nz","top_or_hot":-1,"title":"Update: STAAR Surgical Shares Rise After Wedbush Upgrade Following Q1 Results","media":"MT Newswires Live","content":"<html><body><p> (Updates with recent stock movement and upgrade from Wedbush in headline and first two paragraphs.)</p><p><a href=\"https://laohu8.com/S/STAA\">STAAR Surgical</a> (STAA) shares rose more than 10% in Thursday afternoon trading after Wedbush Securities upgraded the company's stock following the company's Q1 results that beat market expectations.</p><p>The investment firm upgraded the stock to outperform from neutral and adjusted the price target to $40 from $26. Trading volume of STAAR stood at more than 2.7 million shares against a daily average of about 1.3 million.</p><p>The company reported Q1 earnings late Wednesday of $0.10 per diluted share, swinging from a loss of $1.10 a year earlier.</p><p>Analysts surveyed by FactSet expected a loss of $0.05.</p><p>Net sales for the three months ended April 3 rose to $93.5 million from $42.6 million a year earlier.</p><p>Analysts polled by FactSet expected $78.7 million.</p><p>Price: 32.53, Change: +3.13, Percent Change: +10.63</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Update: STAAR Surgical Shares Rise After Wedbush Upgrade Following Q1 Results</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUpdate: STAAR Surgical Shares Rise After Wedbush Upgrade Following Q1 Results\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-05-15 02:30</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> (Updates with recent stock movement and upgrade from Wedbush in headline and first two paragraphs.)</p><p><a href=\"https://laohu8.com/S/STAA\">STAAR Surgical</a> (STAA) shares rose more than 10% in Thursday afternoon trading after Wedbush Securities upgraded the company's stock following the company's Q1 results that beat market expectations.</p><p>The investment firm upgraded the stock to outperform from neutral and adjusted the price target to $40 from $26. Trading volume of STAAR stood at more than 2.7 million shares against a daily average of about 1.3 million.</p><p>The company reported Q1 earnings late Wednesday of $0.10 per diluted share, swinging from a loss of $1.10 a year earlier.</p><p>Analysts surveyed by FactSet expected a loss of $0.05.</p><p>Net sales for the three months ended April 3 rose to $93.5 million from $42.6 million a year earlier.</p><p>Analysts polled by FactSet expected $78.7 million.</p><p>Price: 32.53, Change: +3.13, Percent Change: +10.63</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4588","symbol_name":"碎股","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2635174741","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2635174741","pubTimestamp":1778783458,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"STAAR Surgical  shares rose more than 10% in Thursday afternoon trading after Wedbush Securities upgraded the company's stock following the company's Q1 results that beat market expectations.The investment firm upgraded the stock to outperform from neutral and adjusted the price target to $40 from $26. Trading volume of STAAR stood at more than 2.7 million shares against a daily average of about 1.3 million.The company reported Q1 earnings late Wednesday of $0.10 per diluted share, swinging from a loss of $1.10 a year earlier.Analysts surveyed by FactSet expected a loss of $0.05.Net sales for the three months ended April 3 rose to $93.5 million from $42.6 million a year earlier.Analysts polled by FactSet expected $78.7 million.Price: 32.53, Change: +3.13, Percent Change: +10.63","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4588":"碎股","BK4585":"ETF&股票定投概念","BK4548":"巴美列捷福持仓","STAA":"STAAR Surgical Company","BK4198":"医疗保健用品"},"translate_title":"更新：Wedbush在第一季度业绩公布后升级STAAR Surgical股价上涨","themeId":"a864cd6c65a287045b3e5b828572bce6","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"STAA":1},"content_text":"(Updates with recent stock movement and upgrade from Wedbush in headline and first two paragraphs.)STAAR Surgical (STAA) shares rose more than 10% in Thursday afternoon trading after Wedbush Securities upgraded the company's stock following the company's Q1 results that beat market expectations.The investment firm upgraded the stock to outperform from neutral and adjusted the price target to $40 from $26. Trading volume of STAAR stood at more than 2.7 million shares against a daily average of about 1.3 million.The company reported Q1 earnings late Wednesday of $0.10 per diluted share, swinging from a loss of $1.10 a year earlier.Analysts surveyed by FactSet expected a loss of $0.05.Net sales for the three months ended April 3 rose to $93.5 million from $42.6 million a year earlier.Analysts polled by FactSet expected $78.7 million.Price: 32.53, Change: +3.13, Percent Change: +10.63","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2635174741","isCrawlerRequest":true}